 | • レポートコード：MRC2102QY2688 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のCD抗原がん治療市場について種類別（モノクローナル抗体、抗体薬物複合体、三機能性および二重特異性T細胞エンゲージ抗体、その他）、用途別（病院、診療所、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・CD抗原がん治療市場の概要 ・世界の主要地域別CD抗原がん治療市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のCD抗原がん治療市場規模2015-2026：種類別（モノクローナル抗体、抗体薬物複合体、三機能性および二重特異性T細胞エンゲージ抗体、その他） ・世界のCD抗原がん治療市場規模2015-2026：用途別（病院、診療所、その他） ・CD抗原がん治療の米国市場規模2015-2020 ・CD抗原がん治療のヨーロッパ市場規模2015-2020 ・CD抗原がん治療の中国市場規模2015-2020 ・CD抗原がん治療の日本市場規模2015-2020 ・CD抗原がん治療の東南アジア市場規模2015-2020 ・CD抗原がん治療のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・CD抗原がん治療の製造コスト分析 ・販売チャネル、流通業者、顧客 ・CD抗原がん治療の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global CD Antigen Cancer Therapy Market
The global CD Antigen Cancer Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global CD Antigen Cancer Therapy Scope and Market Size
The global CD Antigen Cancer Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CD Antigen Cancer Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the CD Antigen Cancer Therapy market is segmented into
Monoclonal Antibodies
Antibody-Drug-Conjugates
Tri-Functional and Bi-Specific T-Cell Engager Antibodies
Other
Segment by Application, the CD Antigen Cancer Therapy market is segmented into
Hospitals
Clinics
Other
The CD Antigen Cancer Therapy market is analysed and market size information is provided by regions (countries). Segment by Application, the CD Antigen Cancer Therapy market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and CD Antigen Cancer Therapy Market Share Analysis
CD Antigen Cancer Therapy market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in CD Antigen Cancer Therapy business, the date to enter into the CD Antigen Cancer Therapy market, CD Antigen Cancer Therapy product introduction, recent developments, etc.
The major vendors covered:
AryoGen Biopharma
Biocad
Biogen Idec
Celltrion
Genentech
Genmab
GLYCART Biotechnology
Hetero Drugs
mAbxience
MedImmune
Merck
Sandoz
UCB
1 CD Antigen Cancer Therapy Market Overview
1.1 CD Antigen Cancer Therapy Product Scope
1.2 CD Antigen Cancer Therapy Segment by Type
1.2.1 Global CD Antigen Cancer Therapy Sales by Type (2020-2026)
1.2.2 Monoclonal Antibodies
1.2.3 Antibody-Drug-Conjugates
1.2.4 Tri-Functional and Bi-Specific T-Cell Engager Antibodies
1.2.5 Other
1.3 CD Antigen Cancer Therapy Segment by Application
1.3.1 Global CD Antigen Cancer Therapy Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 CD Antigen Cancer Therapy Market Estimates and Forecasts (2015-2026)
1.4.1 Global CD Antigen Cancer Therapy Sales Growth Rate (2015-2026)
1.4.2 Global CD Antigen Cancer Therapy Revenue and Growth Rate (2015-2026)
1.4.3 Global CD Antigen Cancer Therapy Price Trends (2015-2026)
2 CD Antigen Cancer Therapy Estimate and Forecast by Region
2.1 Global CD Antigen Cancer Therapy Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global CD Antigen Cancer Therapy Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global CD Antigen Cancer Therapy Sales Market Share by Region (2015-2020)
2.2.2 Global CD Antigen Cancer Therapy Revenue Market Share by Region (2015-2020)
2.3 Global CD Antigen Cancer Therapy Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global CD Antigen Cancer Therapy Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global CD Antigen Cancer Therapy Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States CD Antigen Cancer Therapy Estimates and Projections (2015-2026)
2.4.2 Europe CD Antigen Cancer Therapy Estimates and Projections (2015-2026)
2.4.3 China CD Antigen Cancer Therapy Estimates and Projections (2015-2026)
2.4.4 Japan CD Antigen Cancer Therapy Estimates and Projections (2015-2026)
2.4.5 Southeast Asia CD Antigen Cancer Therapy Estimates and Projections (2015-2026)
2.4.6 India CD Antigen Cancer Therapy Estimates and Projections (2015-2026)
3 Global CD Antigen Cancer Therapy Competition Landscape by Players
3.1 Global Top CD Antigen Cancer Therapy Players by Sales (2015-2020)
3.2 Global Top CD Antigen Cancer Therapy Players by Revenue (2015-2020)
3.3 Global CD Antigen Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CD Antigen Cancer Therapy as of 2019)
3.4 Global CD Antigen Cancer Therapy Average Price by Company (2015-2020)
3.5 Manufacturers CD Antigen Cancer Therapy Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key CD Antigen Cancer Therapy Players (Opinion Leaders)
4 Global CD Antigen Cancer Therapy Market Size by Type
4.1 Global CD Antigen Cancer Therapy Historic Market Review by Type (2015-2020)
4.1.1 Global CD Antigen Cancer Therapy Sales Market Share by Type (2015-2020)
4.1.2 Global CD Antigen Cancer Therapy Revenue Market Share by Type (2015-2020)
4.1.3 Global CD Antigen Cancer Therapy Price by Type (2015-2020)
4.2 Global CD Antigen Cancer Therapy Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global CD Antigen Cancer Therapy Sales Forecast by Type (2021-2026)
4.2.2 Global CD Antigen Cancer Therapy Revenue Forecast by Type (2021-2026)
4.2.3 Global CD Antigen Cancer Therapy Price Forecast by Type (2021-2026)
5 Global CD Antigen Cancer Therapy Market Size by Application
5.1 Global CD Antigen Cancer Therapy Historic Market Review by Application (2015-2020)
5.1.1 Global CD Antigen Cancer Therapy Sales Market Share by Application (2015-2020)
5.1.2 Global CD Antigen Cancer Therapy Revenue Market Share by Application (2015-2020)
5.1.3 Global CD Antigen Cancer Therapy Price by Application (2015-2020)
5.2 Global CD Antigen Cancer Therapy Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global CD Antigen Cancer Therapy Sales Forecast by Application (2021-2026)
5.2.2 Global CD Antigen Cancer Therapy Revenue Forecast by Application (2021-2026)
5.2.3 Global CD Antigen Cancer Therapy Price Forecast by Application (2021-2026)
6 United States CD Antigen Cancer Therapy Market Facts & Figures
6.1 United States CD Antigen Cancer Therapy Sales Market Share by Company (2015-2020)
6.2 United States CD Antigen Cancer Therapy Sales Market Share by Type (2015-2020)
6.3 United States CD Antigen Cancer Therapy Sales Market Share by Application (2015-2020)
7 Europe CD Antigen Cancer Therapy Market Facts & Figures
7.1 Europe CD Antigen Cancer Therapy Sales Market Share by Company (2015-2020)
7.2 Europe CD Antigen Cancer Therapy Sales Market Share by Type (2015-2020)
7.3 Europe CD Antigen Cancer Therapy Sales Market Share by Application (2015-2020)
8 China CD Antigen Cancer Therapy Market Facts & Figures
8.1 China CD Antigen Cancer Therapy Sales Market Share by Company (2015-2020)
8.2 China CD Antigen Cancer Therapy Sales Market Share by Type (2015-2020)
8.3 China CD Antigen Cancer Therapy Sales Market Share by Application (2015-2020)
9 Japan CD Antigen Cancer Therapy Market Facts & Figures
9.1 Japan CD Antigen Cancer Therapy Sales Market Share by Company (3015-3030)
9.2 Japan CD Antigen Cancer Therapy Sales Market Share by Type (2015-2020)
9.3 Japan CD Antigen Cancer Therapy Sales Market Share by Application (2015-2020)
10 Southeast Asia CD Antigen Cancer Therapy Market Facts & Figures
10.1 Southeast Asia CD Antigen Cancer Therapy Sales Market Share by Company (2015-2020)
10.2 Southeast Asia CD Antigen Cancer Therapy Sales Market Share by Type (2015-2020)
10.3 Southeast Asia CD Antigen Cancer Therapy Sales Market Share by Application (2015-2020)
11 India CD Antigen Cancer Therapy Market Facts & Figures
11.1 India CD Antigen Cancer Therapy Sales Market Share by Company (2015-2020)
11.2 India CD Antigen Cancer Therapy Sales Market Share by Type (2015-2020)
11.3 India CD Antigen Cancer Therapy Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in CD Antigen Cancer Therapy Business
12.1 AryoGen Biopharma
12.1.1 AryoGen Biopharma Corporation Information
12.1.2 AryoGen Biopharma Business Overview
12.1.3 AryoGen Biopharma CD Antigen Cancer Therapy Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AryoGen Biopharma CD Antigen Cancer Therapy Products Offered
12.1.5 AryoGen Biopharma Recent Development
12.2 Biocad
12.2.1 Biocad Corporation Information
12.2.2 Biocad Business Overview
12.2.3 Biocad CD Antigen Cancer Therapy Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Biocad CD Antigen Cancer Therapy Products Offered
12.2.5 Biocad Recent Development
12.3 Biogen Idec
12.3.1 Biogen Idec Corporation Information
12.3.2 Biogen Idec Business Overview
12.3.3 Biogen Idec CD Antigen Cancer Therapy Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Biogen Idec CD Antigen Cancer Therapy Products Offered
12.3.5 Biogen Idec Recent Development
12.4 Celltrion
12.4.1 Celltrion Corporation Information
12.4.2 Celltrion Business Overview
12.4.3 Celltrion CD Antigen Cancer Therapy Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Celltrion CD Antigen Cancer Therapy Products Offered
12.4.5 Celltrion Recent Development
12.5 Genentech
12.5.1 Genentech Corporation Information
12.5.2 Genentech Business Overview
12.5.3 Genentech CD Antigen Cancer Therapy Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Genentech CD Antigen Cancer Therapy Products Offered
12.5.5 Genentech Recent Development
12.6 Genmab
12.6.1 Genmab Corporation Information
12.6.2 Genmab Business Overview
12.6.3 Genmab CD Antigen Cancer Therapy Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Genmab CD Antigen Cancer Therapy Products Offered
12.6.5 Genmab Recent Development
12.7 GLYCART Biotechnology
12.7.1 GLYCART Biotechnology Corporation Information
12.7.2 GLYCART Biotechnology Business Overview
12.7.3 GLYCART Biotechnology CD Antigen Cancer Therapy Sales, Revenue and Gross Margin (2015-2020)
12.7.4 GLYCART Biotechnology CD Antigen Cancer Therapy Products Offered
12.7.5 GLYCART Biotechnology Recent Development
12.8 Hetero Drugs
12.8.1 Hetero Drugs Corporation Information
12.8.2 Hetero Drugs Business Overview
12.8.3 Hetero Drugs CD Antigen Cancer Therapy Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Hetero Drugs CD Antigen Cancer Therapy Products Offered
12.8.5 Hetero Drugs Recent Development
12.9 mAbxience
12.9.1 mAbxience Corporation Information
12.9.2 mAbxience Business Overview
12.9.3 mAbxience CD Antigen Cancer Therapy Sales, Revenue and Gross Margin (2015-2020)
12.9.4 mAbxience CD Antigen Cancer Therapy Products Offered
12.9.5 mAbxience Recent Development
12.10 MedImmune
12.10.1 MedImmune Corporation Information
12.10.2 MedImmune Business Overview
12.10.3 MedImmune CD Antigen Cancer Therapy Sales, Revenue and Gross Margin (2015-2020)
12.10.4 MedImmune CD Antigen Cancer Therapy Products Offered
12.10.5 MedImmune Recent Development
12.11 Merck
12.11.1 Merck Corporation Information
12.11.2 Merck Business Overview
12.11.3 Merck CD Antigen Cancer Therapy Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Merck CD Antigen Cancer Therapy Products Offered
12.11.5 Merck Recent Development
12.12 Sandoz
12.12.1 Sandoz Corporation Information
12.12.2 Sandoz Business Overview
12.12.3 Sandoz CD Antigen Cancer Therapy Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Sandoz CD Antigen Cancer Therapy Products Offered
12.12.5 Sandoz Recent Development
12.13 UCB
12.13.1 UCB Corporation Information
12.13.2 UCB Business Overview
12.13.3 UCB CD Antigen Cancer Therapy Sales, Revenue and Gross Margin (2015-2020)
12.13.4 UCB CD Antigen Cancer Therapy Products Offered
12.13.5 UCB Recent Development
13 CD Antigen Cancer Therapy Manufacturing Cost Analysis
13.1 CD Antigen Cancer Therapy Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of CD Antigen Cancer Therapy
13.4 CD Antigen Cancer Therapy Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 CD Antigen Cancer Therapy Distributors List
14.3 CD Antigen Cancer Therapy Customers
15 Market Dynamics
15.1 CD Antigen Cancer Therapy Market Trends
15.2 CD Antigen Cancer Therapy Opportunities and Drivers
15.3 CD Antigen Cancer Therapy Market Challenges
15.4 CD Antigen Cancer Therapy Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global CD Antigen Cancer Therapy Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global CD Antigen Cancer Therapy Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market CD Antigen Cancer Therapy Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global CD Antigen Cancer Therapy Sales (K Units) by Region (2015-2020)
Table 5. Global CD Antigen Cancer Therapy Sales Market Share by Region (2015-2020)
Table 6. Global CD Antigen Cancer Therapy Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global CD Antigen Cancer Therapy Revenue Share by Region (2015-2020)
Table 8. Global CD Antigen Cancer Therapy Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global CD Antigen Cancer Therapy Sales Market Share Forecast by Region (2021-2026)
Table 10. Global CD Antigen Cancer Therapy Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global CD Antigen Cancer Therapy Revenue Share Forecast by Region (2021-2026)
Table 12. Global CD Antigen Cancer Therapy (K Units) of Key Companies (2015-2020)
Table 13. Global CD Antigen Cancer Therapy Sales Share by Company (2015-2020)
Table 14. Global CD Antigen Cancer Therapy Revenue (US$ Million) by Company (2015-2020)
Table 15. Global CD Antigen Cancer Therapy Revenue Share by Company (2015-2020)
Table 16. Global CD Antigen Cancer Therapy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CD Antigen Cancer Therapy as of 2019)
Table 17. Global CD Antigen Cancer Therapy Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers CD Antigen Cancer Therapy Manufacturing Sites and Area Served
Table 19. Manufacturers CD Antigen Cancer Therapy Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key CD Antigen Cancer Therapy Players
Table 22. Global CD Antigen Cancer Therapy Sales (K Units) by Type (2015-2020)
Table 23. Global CD Antigen Cancer Therapy Sales Share by Type (2015-2020)
Table 24. Global CD Antigen Cancer Therapy Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global CD Antigen Cancer Therapy Price (K Units) by Type (2015-2020)
Table 26. Global CD Antigen Cancer Therapy Sales Share by Type (2021-2026)
Table 27. Global CD Antigen Cancer Therapy Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global CD Antigen Cancer Therapy Revenue Share by Type (2021-2026)
Table 29. Global CD Antigen Cancer Therapy Price (K Units) by Type (2021-2026)
Table 30. Global CD Antigen Cancer Therapy Sales (K Units) by Application (2015-2020)
Table 31. Global CD Antigen Cancer Therapy Sales Share by Application (2015-2020)
Table 32. Global CD Antigen Cancer Therapy Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global CD Antigen Cancer Therapy Price (K Units) by Application (2015-2020)
Table 34. Global CD Antigen Cancer Therapy Sales (K Units) by Application (2021-2026)
Table 35. Global CD Antigen Cancer Therapy Sales Share by Application (2021-2026)
Table 36. Global CD Antigen Cancer Therapy Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global CD Antigen Cancer Therapy Revenue Share by Application (2021-2026)
Table 38. Global CD Antigen Cancer Therapy Price (K Units) by Application (2021-2026)
Table 39. United States CD Antigen Cancer Therapy Sales (K Units) by Company (2015-2020)
Table 40. United States CD Antigen Cancer Therapy Sales Market Share by Company (2015-2020)
Table 41. United States CD Antigen Cancer Therapy Sales (K Units) by Type (2015-2020)
Table 42. United States CD Antigen Cancer Therapy Sales Market Share by Type (2015-2020)
Table 43. United States CD Antigen Cancer Therapy Sales (K Units) by Application (2015-2020)
Table 44. United States CD Antigen Cancer Therapy Sales Market Share by Application (2015-2020)
Table 45. Europe CD Antigen Cancer Therapy Sales (K Units) by Company (2015-2020)
Table 46. Europe CD Antigen Cancer Therapy Sales Market Share by Company (2015-2020)
Table 47. Europe CD Antigen Cancer Therapy Sales (K Units) by Type (2015-2020)
Table 48. Europe CD Antigen Cancer Therapy Sales Market Share by Type (2015-2020)
Table 49. Europe CD Antigen Cancer Therapy Sales (K Units) by Application (2015-2020)
Table 50. Europe CD Antigen Cancer Therapy Sales Market Share by Type (2015-2020)
Table 51. China CD Antigen Cancer Therapy Sales (K Units) by Company (2015-2020)
Table 52. China CD Antigen Cancer Therapy Sales Market Share by Company (2015-2020)
Table 53. China CD Antigen Cancer Therapy Sales (K Units) by Type (2015-2020)
Table 54. China CD Antigen Cancer Therapy Sales Market Share by Type (2015-2020)
Table 55. China CD Antigen Cancer Therapy Sales (K Units) by Application (2015-2020)
Table 56. China CD Antigen Cancer Therapy Sales Market Share by Application (2015-2020)
Table 57. Japan CD Antigen Cancer Therapy Sales (K Units) by Company (2015-2020)
Table 58. Japan CD Antigen Cancer Therapy Sales Market Share by Company (2015-2020)
Table 59. Japan CD Antigen Cancer Therapy Sales (K Units) by Type (2015-2020)
Table 60. Japan CD Antigen Cancer Therapy Sales Market Share by Type (2015-2020)
Table 61. Japan CD Antigen Cancer Therapy Sales (K Units) by Application (2015-2020)
Table 62. Japan CD Antigen Cancer Therapy Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia CD Antigen Cancer Therapy Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia CD Antigen Cancer Therapy Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia CD Antigen Cancer Therapy Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia CD Antigen Cancer Therapy Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia CD Antigen Cancer Therapy Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia CD Antigen Cancer Therapy Sales Market Share by Application (2015-2020)
Table 69. India CD Antigen Cancer Therapy Sales (K Units) by Company (2015-2020)
Table 70. India CD Antigen Cancer Therapy Sales Market Share by Company (2015-2020)
Table 71. India CD Antigen Cancer Therapy Sales (K Units) by Type (2015-2020)
Table 72. India CD Antigen Cancer Therapy Sales Market Share by Type (2015-2020)
Table 73. India CD Antigen Cancer Therapy Sales (K Units) by Application (2015-2020)
Table 74. India CD Antigen Cancer Therapy Sales Market Share by Application (2015-2020)
Table 75. AryoGen Biopharma Corporation Information
Table 76. AryoGen Biopharma Description and Business Overview
Table 77. AryoGen Biopharma CD Antigen Cancer Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. AryoGen Biopharma CD Antigen Cancer Therapy Product
Table 79. AryoGen Biopharma Recent Development
Table 80. Biocad Corporation Information
Table 81. Biocad Description and Business Overview
Table 82. Biocad CD Antigen Cancer Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Biocad CD Antigen Cancer Therapy Product
Table 84. Biocad Recent Development
Table 85. Biogen Idec Corporation Information
Table 86. Biogen Idec Description and Business Overview
Table 87. Biogen Idec CD Antigen Cancer Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Biogen Idec CD Antigen Cancer Therapy Product
Table 89. Biogen Idec Recent Development
Table 90. Celltrion Corporation Information
Table 91. Celltrion Description and Business Overview
Table 92. Celltrion CD Antigen Cancer Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Celltrion CD Antigen Cancer Therapy Product
Table 94. Celltrion Recent Development
Table 95. Genentech Corporation Information
Table 96. Genentech Description and Business Overview
Table 97. Genentech CD Antigen Cancer Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Genentech CD Antigen Cancer Therapy Product
Table 99. Genentech Recent Development
Table 100. Genmab Corporation Information
Table 101. Genmab Description and Business Overview
Table 102. Genmab CD Antigen Cancer Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Genmab CD Antigen Cancer Therapy Product
Table 104. Genmab Recent Development
Table 105. GLYCART Biotechnology Corporation Information
Table 106. GLYCART Biotechnology Description and Business Overview
Table 107. GLYCART Biotechnology CD Antigen Cancer Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. GLYCART Biotechnology CD Antigen Cancer Therapy Product
Table 109. GLYCART Biotechnology Recent Development
Table 110. Hetero Drugs Corporation Information
Table 111. Hetero Drugs CD Antigen Cancer Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Hetero Drugs Description and Business Overview
Table 113. Hetero Drugs CD Antigen Cancer Therapy Product
Table 114. Hetero Drugs Recent Development
Table 115. mAbxience Corporation Information
Table 116. mAbxience CD Antigen Cancer Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. mAbxience Description and Business Overview
Table 118. mAbxience CD Antigen Cancer Therapy Product
Table 119. mAbxience Recent Development
Table 120. MedImmune Corporation Information
Table 121. MedImmune Description and Business Overview
Table 122. MedImmune CD Antigen Cancer Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. MedImmune CD Antigen Cancer Therapy Product
Table 124. MedImmune Recent Development
Table 125. Merck Corporation Information
Table 126. Merck Description and Business Overview
Table 127. Merck CD Antigen Cancer Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Merck CD Antigen Cancer Therapy Product
Table 129. Merck Recent Development
Table 130. Sandoz Corporation Information
Table 131. Sandoz Description and Business Overview
Table 132. Sandoz CD Antigen Cancer Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Sandoz CD Antigen Cancer Therapy Product
Table 134. Sandoz Recent Development
Table 135. UCB Corporation Information
Table 136. UCB Description and Business Overview
Table 137. UCB CD Antigen Cancer Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. UCB CD Antigen Cancer Therapy Product
Table 139. UCB Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. CD Antigen Cancer Therapy Distributors List
Table 143. CD Antigen Cancer Therapy Customers List
Table 144. CD Antigen Cancer Therapy Market Key Trends
Table 145. CD Antigen Cancer Therapy Key Opportunities and Drivers
Table 146. CD Antigen Cancer Therapy Market Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. CD Antigen Cancer Therapy Product Picture
Figure 2. Global CD Antigen Cancer Therapy Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global CD Antigen Cancer Therapy Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Clinics Examples
Figure 8. Other Examples
Figure 9. Global CD Antigen Cancer Therapy Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global CD Antigen Cancer Therapy Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global CD Antigen Cancer Therapy Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global CD Antigen Cancer Therapy Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global CD Antigen Cancer Therapy Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States CD Antigen Cancer Therapy Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States CD Antigen Cancer Therapy Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe CD Antigen Cancer Therapy Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe CD Antigen Cancer Therapy Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China CD Antigen Cancer Therapy Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China CD Antigen Cancer Therapy Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan CD Antigen Cancer Therapy Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan CD Antigen Cancer Therapy Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia CD Antigen Cancer Therapy Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia CD Antigen Cancer Therapy Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India CD Antigen Cancer Therapy Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India CD Antigen Cancer Therapy Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest CD Antigen Cancer Therapy Players Market Share by Revenue in CD Antigen Cancer Therapy 2015 & 2019
Figure 27. CD Antigen Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global CD Antigen Cancer Therapy Revenue Share by Type (2015-2020)
Figure 29. Global CD Antigen Cancer Therapy Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global CD Antigen Cancer Therapy Revenue Share by Application (2015-2020)
Figure 31. Global CD Antigen Cancer Therapy Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States CD Antigen Cancer Therapy Sales Market Share by Type in 2019
Figure 33. United States CD Antigen Cancer Therapy Sales Market Share by Type in 2019
Figure 34. Europe CD Antigen Cancer Therapy Sales Market Share by Company in 2019
Figure 35. Europe CD Antigen Cancer Therapy Sales Market Share by Type in 2019
Figure 36. Europe CD Antigen Cancer Therapy Sales Market Share by Application in 2019
Figure 37. China CD Antigen Cancer Therapy Sales Market Share by Company in 2019
Figure 38. China CD Antigen Cancer Therapy Sales Market Share by Type in 2019
Figure 39. China CD Antigen Cancer Therapy Sales Market Share by Application in 2019
Figure 40. Japan CD Antigen Cancer Therapy Sales Market Share by Company in 2019
Figure 41. Japan CD Antigen Cancer Therapy Sales Market Share by Type in 2019
Figure 42. Japan CD Antigen Cancer Therapy Sales Market Share by Application in 2019
Figure 43. Southeast Asia CD Antigen Cancer Therapy Sales Market Share by Company in 2019
Figure 44. Southeast Asia CD Antigen Cancer Therapy Sales Market Share by Type in 2019
Figure 45. Southeast Asia CD Antigen Cancer Therapy Sales Market Share by Application in 2019
Figure 46. India CD Antigen Cancer Therapy Sales Market Share by Company in 2019
Figure 47. India CD Antigen Cancer Therapy Sales Market Share by Type in 2019
Figure 48. India CD Antigen Cancer Therapy Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of CD Antigen Cancer Therapy
Figure 51. Manufacturing Process Analysis of CD Antigen Cancer Therapy
Figure 52. CD Antigen Cancer Therapy Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
細胞性腫瘍抗体P53の世界市場レポート2020 Market Analysis and Insights: Global Cellular Tumor Antigen p53 Market The global Cellular Tumor Antigen p53 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Cellular Tumor Antigen p53 Scope and Market Size The global Ce…- 併用療法薬の世界市場レポート2020 Market Analysis and Insights: Global Combination Therapy Drug Market The global Combination Therapy Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Combination Therapy Drug Scope and Market Size The global Combinat…
- 低分子がん治療薬の世界市場レポート2020 Market Analysis and Insights: Global Small Molecule Cancer Drug Market The global Small Molecule Cancer Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Small Molecule Cancer Drug Scope and Market Size The global Sm…
- 陽子線治療装置の世界市場レポート2020 Proton therapy is a type of radiation therapy. It USES a 200-ton device to shoot high-energy particles at the speed of about 2/3 of the speed of light to destroy tumor cells and rarely damage normal human tissues.The technique was first used in patients in the 1950s and perfected in the late 1970s. …
- がん治療用放射性ステントの世界市場レポート2020 Radioactive stent, the self-expanding stent with radioactivity particles is regards as very useful in the treatment of medium and advanced esophageal cancer. Jiangsu Province is the largest suppling place as the top 3 manufacturers are located therem Micro-Tech, Changzhou Zhiye and Changzhou Garson.…